Abstract 5418: The immunomodulatory drug lenalidomide restores a Vitamin D sensitive phenotype to the Vitamin D resistant breast cancer cell line MDA-MB-231: Potential for breast cancer therapeutics
2015 ◽
Keyword(s):
2020 ◽
Vol 59
(6)
◽
pp. 828-834